Loading company…
TWI Pharmaceuticals, Inc develops and commercializes drug therapies, based in Taipei, Taiwan.
TWI Pharmaceuticals, Inc develops and commercializes pharmaceutical products for healthcare providers and patients. Founded in Taipei, Taiwan, the company is listed at the Seed stage and has completed two deals. Its most recent deal was an IPO on December 3, 2013, which raised TWD 3,300.00 mn. In fiscal 2021 it reported revenue of TWD 2,378,730.60 and EBITDA of TWD -150,540.30.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in